| Blood transfusion and management | Lifetime | 6 | US 3 | 99.66 |
| COVID-19 Clinical Research Studies | Lifetime | 62 | US 19 | 99.59 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 14 | US 8 | 99.69 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 9 | US 4 | 99.77 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 90 | US 43 | 99.69 |
| Hemostasis and retained surgical items | Lifetime | 3 | US 2 | 99.61 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 65 | US 28 | 99.74 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 12 | US 5 | 99.46 |
| COVID-19 and healthcare impacts | Lifetime | 68 | US 24 | 98.37 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 155 | US 72 | 99.52 |
| Sepsis Diagnosis and Treatment | Lifetime | 101 | US 38 | 99.46 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 79 | US 26 | 99.12 |
| Mechanical Circulatory Support Devices | Lifetime | 156 | US 97 | 99.15 |
| Hemodynamic Monitoring and Therapy | Lifetime | 222 | US 85 | 98.49 |
| Long-Term Effects of COVID-19 | Lifetime | 427 | US 107 | 96.73 |
| Blood properties and coagulation | Lifetime | 199 | US 112 | 97.72 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 340 | US 137 | 97.18 |
| Hemophilia Treatment and Research | Lifetime | 170 | US 61 | 97.68 |
| Acute Myocardial Infarction Research | Lifetime | 840 | US 345 | 97.54 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 673 | US 247 | 97.10 |
| Blood donation and transfusion practices | Lifetime | 164 | US 76 | 96.23 |
| Drug-Induced Adverse Reactions | Lifetime | 327 | US 101 | 95.66 |
| Cardiac Ischemia and Reperfusion | Lifetime | 771 | US 327 | 95.81 |
| Food Allergy and Anaphylaxis Research | Lifetime | 627 | US 161 | 96.10 |
| Intramuscular injections and effects | Lifetime | 89 | US 32 | 92.34 |
| Biomedical and Chemical Research | Lifetime | 487 | US 90 | 83.56 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 1 | US 1 | 99.23 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 9 | US 4 | 99.72 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | 2021-2025 | 3 | US 2 | 99.60 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 20 | US 4 | 99.56 |
| COVID-19 Clinical Research Studies | 2021-2025 | 254 | US 72 | 98.72 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 205 | US 64 | 98.37 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 254 | US 91 | 97.33 |
| Thermal Regulation in Medicine | 2021-2025 | 18 | US 2 | 95.27 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 38 | US 10 | 96.34 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 135 | US 36 | 95.29 |
| Mechanical Circulatory Support Devices | 2021-2025 | 292 | US 144 | 96.02 |
| Blood transfusion and management | 2021-2025 | 60 | US 31 | 94.36 |
| Hemostasis and retained surgical items | 2021-2025 | 23 | US 2 | 89.68 |
| Blood properties and coagulation | 2021-2025 | 74 | US 25 | 90.32 |
| Climate Change and Health Impacts | 2021-2025 | 599 | US 146 | 91.42 |
| Thermoregulation and physiological responses | 2021-2025 | 155 | US 38 | 92.56 |
| Intramuscular injections and effects | 2021-2025 | 77 | US 13 | 75.02 |